Where does Bayer Healthcare LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Bayer Healthcare LLC ranks #658 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Bayer Healthcare LLC hold?

Bayer Healthcare LLC holds 681 US utility patents granted between 2015 and 2025, spanning 104 technology areas.

What is Bayer Healthcare LLC's Innovation Score?

Bayer Healthcare LLC has an Innovation Score of 66.3 out of 100 (top 1% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Bayer Healthcare LLC's patent grant rate increasing or decreasing?

Bayer Healthcare LLC's recent grant velocity is +11% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Bayer Healthcare LLC's patents?

Bayer Healthcare LLC's patents average 15.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Bayer Healthcare LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Bayer Healthcare LLC

Q: What technology areas does Bayer Healthcare LLC focus on?

Bayer Healthcare LLC's top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 216 patents. Grants appear in 104 CPC subclasses total.

USPTO PatentsView assignee record - 681 granted patents across 104 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Bayer ranks #658 of 49,997 tracked US assignees by granted-patent volume, with 681 patents across 104 technology areas.

#658
of 49,997 US assignees by volume: Top 1%
by Innovation Score (66.3/100): 15.2
avg claims per patent: +11%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R658 · US Corporation #658 · 681 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-MID 681 grants
TOP-DECILE #658/49,997
PHOTO-FINISH M S L L C
CPC-WIDE A61M · 104 areas
INNOV-STRONG 66.3/100
CLAIMS-RICH 15.2 claims/avg
TYPE-USCORP US Corporation
VEL-UP +11% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: M.S. Technologies, L.L.C. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Bayer Healthcare · this assignee

66
Arista Networks · near

66
Philip Morris Products · near

66
Singular Genomics… · near

66
University of… · near

66
3D Lighting… · lowest

7

What this shows Bayer's Innovation Score is 66.3/100 (top 1% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

How Bayer's grant cadence moved

Between 2020–2024, Bayer Healthcare LLC received 323 grants versus 290 in 2015–2019 (+11% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2024 at 85 grants and bottomed in 2020 at 38. Lead class A61M accounts for 31.7% of the portfolio across 104 subclasses. Volume neighbours: GM Cruise Holdings LLC (#654) and Kone Corporation (#662).

Bayer's three-year grant acceleration

From 2019–2021 to 2022–2024, Bayer Healthcare LLC moved from 154 to 222 grants (1.44x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #489. See the growth leaderboard.

GM Cruise Holdings

685
The Brigham and W…

685
Yale University

685
Tianma Microelect…

684
M S L L C

681
Bayer Healthcare ◀

681
Topcon

680
Shinko Electric I…

678
Kone

677

What this shows Bayer holds 681 patents at rank #658, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Bayer

By rank, the assignees closest to #658 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Bayer's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Bayer, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (66 here).

Arista Networks, Inc. 66 Philip Morris Products S.A. 66 Singular Genomics Systems, Inc. 66 University of Virginia Patent Foundation 66

Similar claim depth

Nearest assignees by average claims per patent (15.2 here).

THE Scripps Research Institute 15.2 avg Leidos, Inc. 15.2 avg Hanmi Pharm. Co., Ltd. 15.2 avg Samson Aktiengesellschaft 15.2 avg

Bayer's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

66 Top 1% higher than 99% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Bayer Healthcare LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	57	8.4%
2016	55	8.1%
2017	62	9.1%
2018	63	9.3%
2019	53	7.8%
2020	38	5.6%
2021	63	9.3%
2022	70	10.3%
2023	67	9.8%
2024	85	12.5%
2025partial year	68	10.0%

Which technologies does Bayer Healthcare LLC patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 216

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 142

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 135

C07D - Heterocyclic Compounds 131

A61B - DIAGNOSIS; SURGERY; Identification 92

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 67

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 61

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 46

C07K - Peptides 44

Y10T - Technical Subjects Covered BY Former US Classification 42

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 32

G06T - Image Data Processing OR Generation, IN General 24

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 22

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 21

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 18

Top 15 of 104 technology areas

Where it ranks

Overall rank by patents

#658

of 49,997 tracked assignees

Innovation Score

66.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Bayer Healthcare LLC's patent record in context - here's where to go next.

Bayer Healthcare LLC's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 31.7% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #658 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Bayer Healthcare LLC against GM Cruise Holdings LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 66.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.